WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report)’s stock price gapped down prior to trading on Tuesday . The stock had previously closed at $13.78, but opened at $13.1940. WuXi Biologics (Cayman) shares last traded at $13.20, with a volume of 399 shares changing hands.
Analyst Ratings Changes
Separately, Zacks Research raised shares of WuXi Biologics (Cayman) to a “hold” rating in a report on Friday, August 28th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company presently has an average rating of “Hold”.
View Our Latest Analysis on WXXWY
WuXi Biologics (Cayman) Price Performance
The stock has a 50-day moving average price of $11.53 and a two-hundred day moving average price of $9.65.
WuXi Biologics (Cayman) Company Profile
WuXi Biologics (Cayman) is a global contract research, development and manufacturing organization (CRDMO) focused on biologic medicines. The company provides integrated services to pharmaceutical and biotechnology customers across the development cycle, from early-stage discovery and preclinical research through clinical development, regulatory support and commercial manufacturing.
Its capabilities include the development and production of monoclonal antibodies, recombinant proteins, vaccines, antibody-drug conjugates and other biologic modalities.
Further Reading
- Five stocks we like better than WuXi Biologics (Cayman)
- Microsoft’s 8% Dividend Hike: Confidence Signal or Distraction From Capex Math?
- Paramount Skydance Clears a Major Warner Bros. Discovery Hurdle—Here’s What Comes Next
- Can Apple Overtake NVIDIA as the World’s Most Valuable Company?
- Meta Platforms’ Petal Cable Puts Corning at the Center of AI’s Bandwidth Boom
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
